Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir/Aspart vs NPH/Soluble in Chinese T2D Inpatients
NCT01486966Phase 4Terminated
- Sponsor
- Novo Nordisk
- Start
- Nov 2011
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin detemir, insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Nov 2011; status: terminated.
02
Drugs
insulin detemirinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01486966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486966.